tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market

Cytokinetics (CYTK) Technical Analysis

Compare
1,032 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Cytokinetics’s (CYTK) Moving Averages Convergence Divergence (MACD) indicator is -1.45, suggesting Cytokinetics is a Sell.
Cytokinetics’s (CYTK) 20-Day exponential moving average is 39.91, while Cytokinetics’s (CYTK) share price is $39.48, making it a Sell.
Cytokinetics’s (CYTK) 50-Day exponential moving average is 42.54, while Cytokinetics’s (CYTK) share price is $39.48, making it a Sell.

Cytokinetics (CYTK) Pivot Points

Apr 18, 2025, 11:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
36.63
37.21
38.18
38.76
39.73
40.31
41.28
Fibonacci
37.21
37.80
38.17
38.76
39.35
39.72
40.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cytokinetics (CYTK) Moving Averages

Apr 18, 2025, 11:31 AM
Period
Simple
Exponential
MA5
39.13Buy
38.97Buy
MA10
37.87Buy
38.94Buy
MA20
40.18Sell
39.91Sell
MA50
42.94Sell
42.54Sell
MA100
45.88Sell
45.42Sell
MA200
50.45Sell
49.52Sell
Cytokinetics’s (CYTK) 10-Day exponential moving average is 38.94, while Cytokinetics’s (CYTK) share price is $39.48, making it a Buy.
Cytokinetics’s (CYTK) 100-Day exponential moving average is 45.42, while Cytokinetics’s (CYTK) share price is $39.48, making it a Sell.
Cytokinetics’s (CYTK) stock price is $39.48 and Cytokinetics’s (CYTK) 50-day simple moving average is 42.94, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $39.48 and Cytokinetics’s (CYTK) 100-day simple moving average is 45.88, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $39.48 and Cytokinetics’s (CYTK) 200-day simple moving average is 50.45, creating a Sell signal.

Cytokinetics (CYTK) Technical Indicators

Apr 18, 2025, 11:31 AM
Name
Value
Implied Action
RSI (14)
46.41
Neutral
STOCH (9,6)
77.30
Neutral
STOCHRSI (14)
56.62
Neutral
MACD (12,26)
-1.45
Sell
ADX (14)
21.18
Neutral
Williams %R
-38.44
Buy
CCI (14)
-29.29
Neutral
ATR (14)
2.81
-
Ultimate Oscillator
61.58
Neutral
ROC
-8.59
Sell
Cytokinetics’s (CYTK) Relative Strength Index (RSI) is 46.41, creating a Neutral signal.
Cytokinetics’s (CYTK) Trend Strength Indicator (ADX) is 21.18, creating a Neutral signal.
Cytokinetics’s (CYTK) Commodity Channel Index (CCI) is -29.29, creating a Neutral signal.
Cytokinetics’s (CYTK) Price Rate of Change (ROC) is -8.59, creating a Sell signal.

FAQ

Is CYTK a Buy, Hold, or Sell?
Based on CYTK’s technical indicators, CYTK is a Sell.
    What is CYTK’s RSI (14)?
    CYTK’s RSI (14) is 46.41, which suggests CYTK is a Neutral.
      What is CYTK’s MACD?
      CYTK’s MACD is -1.45, which suggests CYTK is a Sell.
        What is CYTK’s 5-day moving average?
        CYTK’s 5-day moving average is 39.13, which suggests CYTK is a Buy.
          What is CYTK’s 20-day moving average?
          CYTK 20-day moving average is 40.18, which suggests CYTK is a Sell.
            What is CYTK’s 50-day moving average?
            CYTK’s 50-day moving average is 42.94, which suggests CYTK is a Sell.
              What is CYTK’s 200-day moving average?
              CYTK’s 200-day moving average is 50.45, which suggests CYTK is a Sell.
                What is CYTK’s Williams % R (14)?
                CYTK’s Williams % R (14) is -38.44, which suggests CYTK is a Buy.
                  What is CYTK’s CCI (14)?
                  CYTK’s CCI (14) is -29.29, which suggests CYTK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis